| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.3 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.056 | 0.3 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.048 | 0.3 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.3 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |